Form 4: HSAC 2 Holdings, LLC Reduces Stake in Orchestra BioMed Holdings, Inc.
SEC Form 4 Filing
HSAC 2 Holdings, LLC reports a distribution of shares in Orchestra BioMed Holdings, Inc. to its members, resulting in a decreased direct ownership.
Summary
- On August 5, 2024, HSAC 2 Holdings, LLC distributed 3,405,251 shares of Orchestra BioMed Holdings, Inc. common stock to its members.
- The transaction resulted in a decrease in HSAC 2 Holdings, LLC's direct ownership, with the entity now directly owning 1,705,705 shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding changes in ownership positions of company insiders and major shareholders.
Stakeholder Impact
- The share distribution may have a minor impact on the market price of Orchestra BioMed Holdings, Inc., depending on how the members of HSAC 2 Holdings, LLC handle the distributed shares.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Date of the transaction (share distribution). |
| 08/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.